ARTICLE | Company News
Ariad, Bellicum deal
October 16, 2006 7:00 AM UTC
ARIA granted Bellicum a non-exclusive license to Argent cell signaling regulation technology, including the dimerizing compound AP1903, for use in cancer vaccines. ARIA will get an undisclosed equity...